Linical Co., Ltd., a global contract research organization, provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug discovery consulting services, such as market analysis and research of products in development, regulatory affairs, and licensing support. It also provides clinical trial evaluation, statistical analysis, medical writing, pharmacovigilance, clinical monitoring, and contract medical affairs services. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Research context
Linical Co., Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Linical Co., Ltd is currently in a long term uptrend where the price is trading 24.6% above its 200 day moving average.
From a valuation standpoint, the stock is 97.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Linical Co., Ltd's total revenue sank by 9.4% to $3B since the same quarter in the previous year.
Its net income has increased by 1.5% to $171M since the same quarter in the previous year.
Based on the above factors, Linical Co., Ltd gets an overall score of 3/5.